Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

Authors:
  • ASAngela Puente Sanchez
    Angela Puente Sanchez
  • FTFanny Turon
    Fanny Turon
  • JMJavier Martinez
    Javier Martinez
  • JFJose Ignacio Fortea
    Jose Ignacio Fortea
  • MHManuel Hernandez-Guerra
    Manuel Hernandez-Guerra
  • EAEdilmar Alvarado-Tapias
    Edilmar Alvarado-Tapias
  • MPMonica Pons
    Monica Pons
  • MMMarta Magaz
    Marta Magaz
  • ELElba Llop
    Elba Llop
  • CÁCarmen Álvarez-Navascués
    Carmen Álvarez-Navascués
  • JAJosé Castellote Alonso
    José Castellote Alonso
  • MBMarina Berenguer
    Marina Berenguer

Abstract
No abstract available